Medical AI Alliance
← Company Index
Medical AIKOSDAQ 0007C0Innovative Medical Device7 approvals

Acryl Inc.

Official website

Founded in 2011, Acryl provides the integrated AI platform Jonathan and the healthcare-specialized AI platform Nadia.

As of 2026-10-10, Acryl Inc. has 1 MFDS Innovative Medical Device designation, 6 Korean MFDS device approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2011 and listed on KOSDAQ in 2025, Acryl is an AI company. It offers the integrated AI platform Jonathan and the healthcare-specialized AI platform Nadia, using Nadia to develop and commercialize AI-based digital medical devices. Its R&D is organized into the AI R&D Innovation Group, the AX Business Group, and the Healthcare Business Group, with the AX Business Group running B2B and B2G projects based on the Jonathan platform.

Products & technology

  • JonathanIntegrated AI platform for industry-specific AI agents and B2B/B2G projects
  • NadiaHealthcare-specialized AI platform for developing and commercializing AI-based digital medical devices

Regulatory approvals

data.go.kr

1 Innovative Medical Device designations · 2026 / 6 Korean MFDS device approvals · 2024–2025

  • InnovativeEP-01-232026-02-09
    Innovative Medical Device designation
  • MFDSProstate disease risk assessment software2025-07-18
    Product approval · Class 2제허 25-480 호
  • MFDSProduct name not recorded2025-07-18
    Product approval · Class 2허 25-480 호
  • MFDSUltrasound image, computer aided detection /diagnosis software, class 22025-02-11
    Product approval · Class 2제허 25-84 호
  • MFDSProduct name not recorded2025-02-11
    Product approval · Class 2허 25-84 호
  • MFDSPsychological assessment software2024-12-20
    Product approval · Class 2제허 24-891 호
  • MFDSProduct name not recorded2024-12-20
    Product approval · Class 2허 24-891 호

R&D and key agreements

Source: DART corporate disclosure

AI 인프라 및 자체 LLM 개발 · AI R&D Innovation Group handles AI infrastructure system design and proprietary LLM development

AAAI 랩 · Researches GPU optimization and core AX infrastructure technology

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 69 more patents

AI reads

MAA server logs · IP-verified
57
Times AI engines pulled Acryl Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

56
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

11
live 0
Last 7 days
49
live 1
Last 30 days
57
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot44
  • PerplexityPerplexityBot8
  • GoogleGoogleOther2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Acryl Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryMedical AI

SEERS Co., Ltd.100

Founded in 2009, SEERS provides the wearable ECG analysis solution mobiCARE and the inpatient monitoring solution thynC, based on AI vital-sign analytics.

INFINITT Healthcare Co., Ltd.85

Founded in 2002, INFINITT Healthcare provides PACS-centered medical imaging software and AI diagnostic aids across multiple clinical specialties.

SyntekaBio,Inc.85

Founded in 2009, SyntekaBio provides genomic big data-based AI drug discovery platforms DeepMatcher and NEO-ARS, along with the NGS-ARS precision medicine service.

DEEPNOID Inc.85

Founded in 2008 and listed on KOSDAQ in 2021, DEEPNOID develops medical and industrial AI imaging solutions like DEEP:NEURO.

VUNO, Inc.85

Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.

JLK, Inc.80

JLK offers the stroke AI solution MEDIHUB STROKE and holds 78 global regulatory approvals, including US FDA and Japan PMDA clearances.

Lunit Inc.80

Founded in 2013, Lunit provides AI-driven cancer screening and oncology solutions through Lunit INSIGHT and Lunit SCOPE.

LEMON HEALTHCARE Co.70

Founded in 2017 and listed on KOSDAQ in 2026, Lemon Healthcare operates the LDB medical mydata relay platform for hospitals and insurers.

SELVAS AI Inc.60

SELVAS AI provides voice and language AI technologies through its HCI and AI Digital Transformation business units.

ezCaretech Co., LTD60

Founded in 2001, ezCaretech provides the hospital information systems BESTCare (on-premise) and EDGE&NEXT (cloud-based).

BITComputer55

Founded in 1985, BITComputer provides hospital information systems such as bitnixHIS and CLEMR, alongside digital healthcare and IT education businesses.

NEUROPHET Inc.35

Founded in 2016 and listed on KOSDAQ in 2025, Neurophet develops AI brain-imaging solutions AQUA, SCALE PET, and AQUA AD.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition